Vijaya Diagnostic AGM 2026: ₹2 Dividend, Key Dates

What the company has announced

Vijaya Diagnostic Centre has scheduled its 24th Annual General Meeting (AGM) for Thursday, September 24, 2026 at 11:00 am (IST). The company said the AGM will be held through Video Conferencing or Other Audio Visual Means (VC/OAVM), in line with applicable circulars. A key item on the agenda is shareholder approval for the final dividend for the financial year ended March 31, 2026 (FY26). The board has recommended a final dividend of ₹2 per equity share of face value ₹1 each, described as a 200% payout. The company has also communicated key dates for record date and remote e-voting.

Dividend proposal for FY26

The board recommendation is for a final dividend of ₹2 per share for FY26, subject to shareholder approval at the AGM. The dividend will be paid to eligible shareholders whose names appear in the Register of Members, or who are shown as beneficial owners by NSDL and CDSL, as of the record date. The company has stated that, if approved, the final dividend will be credited within 30 days from the date of the AGM. The dividend proposal is linked to the record date fixed by the company for determining entitlement.

Record date fixed for dividend and voting eligibility

Vijaya Diagnostic Centre has fixed Wednesday, September 16, 2026 as the record date for determining shareholder entitlement to the final dividend. The same date also serves as the cut-off date for voting rights for the AGM. Voting rights are to be computed based on the paid-up value of shares as at the close of business hours on September 16, 2026.

E-voting window and platform

For shareholders who plan to vote remotely, the company has enabled remote e-voting through KFin Technologies Limited. The remote e-voting begins at 9:00 am on Monday, September 21, 2026 and ends at 5:00 pm on Wednesday, September 23, 2026. The company has referenced Section 108 of the Companies Act, 2013 and SEBI LODR Regulations in relation to the e-voting process.

AGM agenda items highlighted by the company

Along with dividend approval, the company said the AGM will formally present financial reports. The communication also mentions that approvals will be sought for dividends and ESOP modifications. The AGM notice sets out the business to be transacted at the meeting, with participation enabled through VC/OAVM.

Key dates at a glance

Recent financial performance snapshots

The company has also shared recent quarterly metrics that provide context on operating trends. In Q1FY27, Total Income was ₹239.51 crore, up 22.76% year-on-year from ₹195.10 crore in Q1FY26, and up 8.00% quarter-on-quarter from ₹221.78 crore in Q4FY26. Revenue from operations in Q1FY27 was ₹230.98 crore, up 22.83% year-on-year from ₹188.05 crore in Q1FY26, and up 5.29% quarter-on-quarter from ₹219.38 crore in Q4FY26. Profit before tax in Q1FY27 stood at ₹70.94 crore, up 35.89% year-on-year from ₹52.21 crore in Q1FY26, and up 10.39% quarter-on-quarter from ₹64.27 crore in Q4FY26. Total comprehensive income in Q1FY27 was ₹53.28 crore, compared with ₹38.52 crore in Q1FY26 and ₹48.38 crore in Q4FY26. Basic EPS for Q1FY27 was ₹5.16 versus ₹3.76 in Q1FY26 and ₹4.66 in Q4FY26.

Corporate actions and business updates referenced

Separately, the company has reported a board meeting outcome under Regulation 30 of SEBI (LODR) Regulations, 2015 relating to inorganic growth. It said approval was granted for execution of a Business Transfer Agreement (BTA) for 100% acquisition of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam on a slump sale basis, subject to fulfilment of conditions precedent and other terms set out in the BTA.

The company also stated that at its board meeting held on May 7, 2026, it approved the acquisition of the business of Medinova Millennium MRI Services LLP (a 100% owned entity) by way of a slump sale. The same May 7, 2026 board meeting is also referenced for the dividend recommendation of ₹2 per share for FY26, subject to shareholder approval.

Market and investor relevance

For investors, the dividend timeline matters mainly because the record date determines both eligibility for the dividend and voting rights at the AGM. The e-voting dates provide a defined window for shareholders who do not plan to attend the VC/OAVM meeting live. The disclosure also provides clarity on the expected timeline for dividend credit, which the company has said would be within 30 days from the AGM date if shareholders approve it.

The provided market snapshot shows an LTP of ₹1,574 with a 0.36% move, and a 5-year figure of 19%. These data points, alongside the board’s dividend recommendation and the AGM schedule, will likely be tracked by shareholders as the record date approaches.

Conclusion

Vijaya Diagnostic Centre’s calendar for September 2026 sets clear milestones for shareholders, including the record date on September 16, the remote e-voting window from September 21 to 23, and the AGM on September 24 via VC/OAVM. The proposed FY26 final dividend of ₹2 per share remains subject to shareholder approval at the AGM, after which the company has said the payout would be credited within 30 days.